Delusions: Clinical Trials

10 trials for Delusions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 10

Follow Delusions: new trials by email Literature Review of Delusions trials Research Report on Delusions

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With Schizophrenia
cognitive defusion techniques - Schizophrenia; Psychosis, Nurse's Role
Not applicableCompletedAlexandria University702022-09-102023-07-19
Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".
Cognitive Behavioural Virtual Reality Therapy., Traditional Cognitive Behavioural Therapy - Paranoid Schizophrenia, Schizophrenia and Related Disorders
Not applicableCompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2592021-04-092026-08-12
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis
emotion-oriented Cognitive Behavior Therapy - Schizophrenia, Psychotic Disorders
Not applicableCompletedPhilipps University Marburg942016-05-012020-03-05
Effect of 4-session Metacognitive Training in Chinese Adult Outpatients With Schizophrenia Spectrum Disorders and Major Depressive Disorder
Metacognitive Training - Delusions, Depression
Not applicableCompletedChinese University of Hong Kong1132015-04-012020-01-23
Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series
Self Directed Positive Parenting Program - Schizophrenia, Spectrum
Not applicableCompletedUniversity of Manchester12014-06-012016-08-02
Metacognitive Training in Schizophrenia
Metacognitive training, Cognitive Remediation - Delusions, Schizophrenia
Not applicableCompletedUniversitätsklinikum Hamburg-Eppendorf602009-09-012015-03-03
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
Cognitive-Behavior Therapy, Standard Psychiatric Treatment - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedNew York State Psychiatric Institute342008-11-012012-12-13
Acceptance and Commitment Therapy for Delusions
Acceptance and Commitment Therapy - Schizophrenia, Delusional Disorder
Not applicableCompletedWeill Medical College of Cornell University42008-04-012009-10-12
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) - Paranoid Delusions
Not applicableCompletedWeill Medical College of Cornell University242006-09-012018-12-04
CATIE-Alzheimer's Disease Trial
Olanzapine, Quetiapine, Risperidone - Alzheimer's Disease
Not applicableCompletedNational Institute of Mental Health (NIMH)4502001-03-012015-06-17

Narrower conditions

Psychotic Disorders (9)  ·  Schizophrenia (7)  ·  Paranoid Disorders (4)  ·  Hallucinations (3)  ·  Mental Disorders (2)  ·  Schizophrenia, Paranoid (2)  ·  Alzheimer Disease (1)  ·  Behavioral Symptoms (1)  ·  Dementia (1)  ·  Depression (1)  ·  Disease (1)  ·  Emotional Regulation (1)  ·  Psychomotor Agitation (1)  ·  Schizotypal Personality Disorder (1)

Broader conditions

Behavior (10)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (10)  ·  Behavioral Symptoms (9)  ·  Mental Disorders (8)  ·  Nervous System Diseases (4)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Perceptual Disorders (3)  ·  Signs and Symptoms (3)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dyskinesias (1)  ·  Dyssomnias (1)

Interventions

Acceptance and Commitment Therapy (1)  ·  Citalopram (1)  ·  Cognitive Behavioral Therapy (1)  ·  Cognitive Remediation (1)  ·  Olanzapine (1)  ·  Quetiapine Fumarate (1)  ·  Risperidone (1)  ·  Therapeutics (1)

Sponsors

Weill Medical College of Cornell University (2)  ·  Alexandria University (1)  ·  Chinese University of Hong Kong (1)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  New York State Psychiatric Institute (1)  ·  Philipps University Marburg (1)  ·  University of Manchester (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)

Countries

United States (4)  ·  Germany (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  United Kingdom (1)

Top investigators

Ayman Mohamed El-Ashry, PHD (1)  ·  David Kimhy, Ph.D. (1)  ·  Lon Schneider, MD (1)  ·  Pierre Tariot, MD (1)  ·  Prof Rachel Calam, PhD (1)  ·  Steffen Moritz, PhD (1)  ·  Stephanie Mehl, Ph. D. (1)  ·  Tania M Lincoln, Ph. D. (1)  ·  Tobias Teismann, Ph. D. (1)  ·  Yulia Landa, Psy D. (1)  ·  Yulia Landa, Psy.D. (1)

Results publications

PMID 17035647, PMID 17984395, PMID 18519523, PMID 19369318, PMID 20214847, PMID 28215900, PMID 29045769, PMID 32074412, PMID 32105124, PMID 33176899, PMID 33211503, PMID 38736628, PMID 40804323, PMID 41702910, PMID 42037481

NIH funding

K23MH077653 (1), N01MH090001 (1), N01MH90001 (1)